PROXIMAGEN NEUROSCIENCE PLC ("Proximagen" or "the Company") Notification of Interim Results for the Six Months Ended 31 May 2007 London, UK, 14 August 2007 Proximagen Neuroscience plc (AIM: PRX), the specialty drug discovery and development company focused on neurodegenerative diseases, will announce its Interim Results for the six months ended 31 May 2007 on Wednesday 29 August 2007. Analyst Briefing: An analyst briefing will be held at 11:00am on 29 August at the offices of Buchanan Communications, 45 Moorfields, London EC2. For more information please contact:
|